Pfizer considers purchase of India's Agila Specialties
Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd , for a possible price of $2 billion, Bloomberg reported on Monday.
Like this story, share it with millions of investors on M3
Pfizer considers purchase of India's Agila Specialties
Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd , for a possible price of $2 billion, Bloomberg reported on Monday.
Like this story, share it with millions of investors on M3
Pfizer considers purchase of India's Agila Specialties
Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd , for a possible price of $2 billion, Bloomberg reported on Monday.
Pfizer Inc is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of USD 2 billion, Bloomberg reported on Monday.
Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.
